MarketsandMarkets Conferences (MnM Conferences) is delighted to announce the inaugural Cancer Diagnosis & Therapy Congress to be held on September 3 - 4, 2015 London, UK focusing on the theme of “Advancement in Cancer diagnosis, treatment and challenges in organ specific cancer treatment”.
The two day program will address key concerns such as cancer Immunotherapy, molecular targeted therapy, metabolomics in cancer tumour assessments & profiling, nanotechnology in cancer therapy, hormone therapy, stem cell Transplantation, surgical oncology, epigenetics, cancer genomics, cancer biomarkers, bio banking, non-invasive cancer diagnostics, organ specific cancers, cancer epidemiology and clinical trial in cancer research.
Speaker of the month:
Prof. Pedro Rondot Radío - University of Buenos Aires, Army Social Security - Argentina
Prof. Radio will be presenting at the congress on 'Biobanking International Harmonization and Globalization'. We recently conducted an interview with him to discuss the various developments in his field, here are his inputs.
• How will international harmonization & globalization of biobanks aid in diagnosis and treatments of diseases?
Rapid developments in medical research produce a continuous stream of new knowledge about disease process. However the possibility for early detection, or preferably prevention of disease remains limited. Population-based prospective studies investigating the interaction between genetic predisposition to a disease and exposure to environmental factors are a prerequisite to gain knowledge for the development of the preventive strategies. Increasingly it is being realised that biobanking – systematically assembling collection of material and other relevant information about the individuals- will play a key role in achieving the medical paradigm shift from cure to prevention.
The developments of new treatments, prevention strategies and the promotion of health requires three steps:establisment of diagnostic patterns, elucidation of the molecular processes involved, and understanding of the causal pathway.
As the studies of complex diseases requires comparison of large numbers of affected and unaffected individuals (“cases” & “controls”), different kind of biobanks have thus become indispensable to elucidate molecular processes and aetiology pathways, to translate biomedical research into real improvements in healthcare.
• What are the immediate to be taken to ensure international harmonization & globalization of biobanks?
To this end, large and well-organised biobanks have already been established, are underway or are planned to start in the future. They contain data on health, nutrition, environmental factors, demographic, socioeconomic and lifestyle variables, combined with well-preserved biological material from patients and healthy individuals. The integration of these resources with powerful “omics” approaches (genomics, transcriptomics, metabolomics and proteomics), integrated by bioinformatics, promises to greatly advance our understanding of disease development, thus leading to new ways to prevent or even cure many chronic and life-threatening diseases worldwide.
For more information download agenda